Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01603784 · ClinicalTrials.gov registry record · Phase 3
Combining Exercise and Cognitive Training to Improve Everyday Function
A Phase 3 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 96
- Enrollment target
NCT01603784: Completed Phase 3 study, sponsored by Washington University School of Medicine.
NCT01603784 is a Phase 3 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 96 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01603784, a Phase 3 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of this randomized, controlled, prospective study is to evaluate the benefits of combining aerobic exercise with cognitive training for optimizing cognitive function. The study will enroll 109 men and women, age 55-75 years who are in stable health and without contraindications to exercise or evidence of dementia or cognitive impairment. Individuals will be randomly assigned to one of four groups for six months: Aerobic Exercise and Health Education, Home Exercise and Cognitive Training, Aerobic Exercise and Cognitive Training, and Home Exercise and Health Education. Participants will undergo measurements of cognitive function, physical performance, and complete questionaires about daily activities, physical activity, and quality of life at baseline (pre-intervention), and at 6 and 12 months after baseline.
Primary Outcome
This task measures the ability of the individual to learn and recall complex medical information, and the source of the information.
Interventions
- BEHAVIORAL Health Education
- BEHAVIORAL Cognitive Training
- BEHAVIORAL Home Exercise
- BEHAVIORAL Intensive Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-06 |
| Phase | Phase 3 |
What the finished NCT01603784 record still lists
NCT01603784 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 4 interventions - of which Health Education is the first listed.
NCT01603784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01603784 about?
NCT01603784 is a clinical study titled "Combining Exercise and Cognitive Training to Improve Everyday Function". The purpose of this randomized, controlled, prospective study is to evaluate the benefits of combining aerobic exercise with cognitive training for optimizing cognitive function. The study will enroll 109 men and women, age 55-75 years who are in stable health and without contraindications to exerci...
What is the current status of trial NCT01603784?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 96 participants. The study started on 2010-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01603784?
The interventions under investigation include: Health Education (BEHAVIORAL), Cognitive Training (BEHAVIORAL), Home Exercise (BEHAVIORAL), Intensive Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT01603784?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01603784's enrollment target sits among peer trials
96 1718th of 2000 higher than 282 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia